Press Releases
New Study Demonstrates Cost Effectiveness of NeuroStar
®
TMS Therapy in the Treatment of Depression, November 6, 2008
FDA Clears NeuroStar
®
TMS Therapy for the Treatment of Depression, October 8, 2008
New Data Analysis Identifies Depressed Patients Who are
Most Likely to Benefit From Treatment with NeuroStar TMS Therapy, May 5, 2008
NeuroStar® TMS Therapy Demonstrated Safety and Tolerability in Depression Clinical Trials According to Recent Peer-Reviewed Publication, February, 29, 2008
NeuroStar® TMS Therapy Produced Significant Improvements in Depression Symptoms in Recently-Published Randomized, Controlled Trial, June 15, 2007
NeuroStar® TMS Therapy Improved Quality of Life in Patients with Major Depression in Clinical Trials, May 21, 2007
FDA Advisory Panel provides positive review on safety of NeuroStar
®
TMS Therapy for patients with depression, January 26, 2007
Neuronetics Announces Positive Multicenter Clinical Trial Results with TMS Therapy for Treating Depression
Neuronetics Prepares for Product Launch, April 10, 2006
New Treatment options emerging for Major Depression, May 21, 2005
New Investigational Procedure to Treat Major Depression Being Tested in Global University Medical and Clinical Research Centers, May 2, 2005
